Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000253·Protagonist Therapeutics, Inc
Schedule 13G ownership disclosure
Protagonist Therapeutics Inc
Common Stock · CUSIP: 74366E102
Event date: 2025-12-31
- Filing-level shares
- 5,413,690
- Percent of class
- 8.65%
- The Vanguard Group
Shares: 5,413,690 · Class: 8.65%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000253
- Form type
- SCHEDULE 13G/A
- Filer
- Protagonist Therapeutics, Inc
- CIK
- CIK 1377121
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership